These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10746033)

  • 1. [Chronic rejection of renal allografts. Part 1. Present knowledge of etiopathogenesis].
    Viklický O; Matl I; Heemann UW
    Cas Lek Cesk; 1999 Nov; 138(23):711-5. PubMed ID: 10746033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contribution of reduced functioning mass to chronic kidney allograft dysfunction in rats.
    Heemann UW; Azuma H; Tullius SG; Mackenzie H; Brenner BM; Tilney NL
    Transplantation; 1994 Dec; 58(12):1317-22. PubMed ID: 7528948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathogenesis of chronic renal allograft dysfunction].
    Morozumi K; Takeda A; Uchida K
    Hinyokika Kiyo; 2002 Nov; 48(11):673-7. PubMed ID: 12512140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology of chronic rejection.
    Häyry P
    Transplant Proc; 1996 Dec; 28(6 Suppl 1):7-10. PubMed ID: 8962407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular expression of adhesion molecules in acute and chronic rejection of kidney allografts.
    Jurcić V; Ferluga D
    Adv Clin Path; 2003 Jan; 7(1):33-7. PubMed ID: 19774735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Causes of late renal transplant dysfunction].
    Szabó A; Müller V
    Orv Hetil; 2002 Dec; 143(51):2811-9. PubMed ID: 12638307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of chronic renal allograft rejection.
    Lemström K; Koskinen P; Häyry P
    Kidney Int Suppl; 1995 Dec; 52():S2-10. PubMed ID: 8587277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential therapeutic interventions to avoid or treat chronic allograft dysfunction.
    Kahan BD
    Transplantation; 2001 Jun; 71(11 Suppl):SS52-7. PubMed ID: 11583490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor (VEGF) ligand and receptor induction in rat renal allograft rejection.
    Rintala SE; Savikko J; Rintala JM; von Willebrand E
    Transplant Proc; 2006 Dec; 38(10):3236-8. PubMed ID: 17175233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of chronic allograft rejection.
    Joosten SA; van Kooten C; Paul LC
    Transpl Int; 2003 Mar; 16(3):137-45. PubMed ID: 12664207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA fragmentation in acute and chronic rejection after renal transplantation.
    Ott U; Aschoff A; Fünfstück R; Jirikowski G; Wolf G
    Transplant Proc; 2007; 39(1):73-7. PubMed ID: 17275477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of atorvastatin on chronic allograft nephropathy in rats.
    Zhang W; Liu M; Wu Y; Zhu P; Yin C; Zhang W; Gu M
    J Surg Res; 2007 Dec; 143(2):428-36. PubMed ID: 17628598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [[Chronic renal allograft rejection. Part 2. Therapeutic possibilities] ].
    Viklický O; Matl I; Lácha J; Muller V; Szabo A; Heemann UW
    Cas Lek Cesk; 2000 Aug; 139(17):524-8. PubMed ID: 11109284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic allograft nephropathy: expression and localization of PAI-1 and PPAR-gamma.
    Revelo MP; Federspiel C; Helderman H; Fogo AB
    Nephrol Dial Transplant; 2005 Dec; 20(12):2812-9. PubMed ID: 16221712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causes of late renal allograft loss: chronic allograft dysfunction, death, and other factors.
    Kreis HA; Ponticelli C
    Transplantation; 2001 Jun; 71(11 Suppl):SS5-9. PubMed ID: 11583489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Nephrol Dial Transplant; 2008 Nov; 23(11):3446-55. PubMed ID: 18558624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive immunohistological analysis of the endothelin system in human kidney grafts.
    Frank K; Zeier M; Gross ML; Waldherr R; Ritz E; Amann K
    Nephrol Dial Transplant; 2006 May; 21(5):1365-72. PubMed ID: 16449275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of tissue factor (TF) in calcineurin inhibitor-induced nephrotoxicity and rejection--implications for development of a possible diagnostic marker.
    Osterholm C; Veress B; Simanaitis M; Hedner U; Ekberg H
    Transpl Immunol; 2005 Dec; 15(2):165-72. PubMed ID: 16412961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic allograft dysfunction: mechanisms and new approaches to therapy.
    Womer KL; Vella JP; Sayegh MH
    Semin Nephrol; 2000 Mar; 20(2):126-47. PubMed ID: 10746856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early acute rejection does not affect chronic allograft nephropathy and death censored graft failure.
    He X; Johnston A
    Transplant Proc; 2004 Dec; 36(10):2993-6. PubMed ID: 15686679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.